Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
50S ribosomal protein L32 is a structural component of the large (50S) subunit of prokaryotic ribosomes. It is essential for ribosome assembly, stability, and translation. It interacts with rRNA and other ribosomal proteins. The eukaryotic homolog, RPL32, has been implicated in cancer.
Inhibition of bacterial protein synthesis by disrupting ribosome function.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 50S Ribosomal Protein L32 (L32).